GCH-I Antibodies

Santa Cruz Biotechnology features a diverse variety of GCH-I monoclonal antibodies for investigating GTP cyclohydrolase I (GCH-I) in various biological processes. GCH-I Antibodies are validated for multiple applications including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). GCH-I is a critical enzyme in the biosynthesis of tetrahydrobiopterin, a cofactor essential for the production of neurotransmitters such as dopamine, serotonin, and norepinephrine. Its proper function is vital for maintaining normal neurological function and has implications in various disorders, including phenylketonuria and certain neurodegenerative diseases. Understanding the expression and regulation of GCH-I can provide insights into these conditions and aid in the development of therapeutic strategies. GCH-I monoclonal antibodies enable precise detection and analysis of GCH-I expression patterns across different tissues and experimental conditions. Researchers can explore the molecular mechanisms underlying GCH-I function and regulation with exceptional specificity and reliability. Santa Cruz Biotechnology monoclonal antibodies for GCH-I support cutting-edge research that advances our understanding of neurological disorders and potential therapeutic approaches.